Itamar Medical Ltd (ITMR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Itamar Medical Ltd (ITMR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6572
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, markets and sells diagnostic medical devices for the diagnosis and treatment of sleep apnea. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction assessment tool for risk classification; and WatchPAT, a diagnostic device which provides accurate screening, detection, and diagnosis of sleep apnea and sleep disorders. Itamar Medical conducts research and development of non-invasive medical equipment for diagnosis of several medical conditions such as cardiovascular disease and respiratory disorders. The company’s products find application in research centers, clinical institutions and pharmaceutical clinical phase studies. It has operations in Israel, the Netherlands, Japan and the US. Itamar Medical is headquartered in Caesarea, Israel.

Itamar Medical Ltd (ITMR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Itamar Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Itamar Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Itamar Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Itamar Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Itamar Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Itamar Medical Ltd, Medical Equipment, Deal Details 10
Private Equity 10
Viola Private Equity to Invest USD24 Million in Itamar Medical 10
Partnerships 11
Itamar Medical Enters into Distribution Agreement with Nihon Kohden for EndoPAT 11
Equity Offering 12
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Itamar Medical Completes Private Placement Of US$6.8 Million 14
Asset Transactions 15
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 15
Itamar Medical Ltd – Key Competitors 16
Itamar Medical Ltd – Key Employees 17
Itamar Medical Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 13, 2018: Itamar Medical announces second quarter 2018 financial results 19
Mar 22, 2018: Itamar Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Itamar Medical Ltd, Medical Equipment, Key Facts, 2017 2
Itamar Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Itamar Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Itamar Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Itamar Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Itamar Medical Ltd, Deals By Market, 2012 to YTD 2018 8
Itamar Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Viola Private Equity to Invest USD24 Million in Itamar Medical 10
Itamar Medical Enters into Distribution Agreement with Nihon Kohden for EndoPAT 11
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Itamar Medical Completes Private Placement Of US$6.8 Million 14
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 15
Itamar Medical Ltd, Key Competitors 16
Itamar Medical Ltd, Key Employees 17
Itamar Medical Ltd, Subsidiaries 18

List of Figures
Itamar Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Itamar Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Itamar Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Itamar Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Itamar Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Itamar Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Itamar Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Itamar Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Itamar Medical Ltd (ITMR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • CD Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc is an integrated diagnostics company that develops immunoassays that improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, in …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • WH Group Limited (288):企業の財務・戦略的SWOT分析
    WH Group Limited (288) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cathedral Energy Services Ltd (CET):石油・ガス:M&Aディール及び事業提携情報
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, measurement while drilling services, production testing services, …
  • Capture Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that offers mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and anchoring capabilitie …
  • General Electric Company:戦略・SWOT・企業財務分析
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rexel S.A.:企業の戦略・SWOT・財務情報
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • General Dynamics Ordnance and Tactical Systems, Inc.:企業の戦略・SWOT・財務情報
    General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Graham Group Ltd:企業の戦略・SWOT・財務情報
    Graham Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Graham Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vodacom Group Ltd (VOD):企業の財務・戦略的SWOT分析
    Vodacom Group Ltd (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Antabio SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Antabio SAS (Antabio) is a biopharmaceutical company that develops novel antibacterials targeting drug-resistant pathogens. The company’s pipeline products comprise Metallo Beta-Lactamases inhibitors, Pseudomonas Biofilms inhibitors and others. It uses in vitro technologies and bacterial dis …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Invenra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Invenra Inc (Invenra) is a biotechnology company that discovers and develops multispecific antibodies for immuno-oncology. The company’s pipeline products include t-cell redirecting b-bodies, OX40 agonist, treg depleter SNIPER and exelixis B-Body. Its B-Body and SNIPER technologies are used …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Mitsubishi Ufj Financial Group Inc:企業の戦略・SWOT・財務分析
    Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Immucor Inc:企業の戦略的SWOT分析
    Immucor Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Brunswick Corporation (BC):企業の財務・戦略的SWOT分析
    Brunswick Corporation (BC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • DeRoyal Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary DeRoyal Industries Inc (DeRoyal) is a medical device company that develops, manufactures and markets healthcare products. The company’s products portfolio includes surgical instruments and accessories, acute care products, patient protection products, orthopedics, rehabilitation products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆